PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells

LTA4H extensively associates with mRNAs and lncRNAs indicative of its novel regulatory targets

(2023) Tianjiao Ren et al.   PeerJ

Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages

(2022) Yaxin Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer

(2022) Jufang Guo et al.   Biomed Research International

Research progress on RNA−binding proteins in breast cancer

(2022) Ying Chen et al.   Frontiers in Oncology

In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells

(2022) Zhongji Zhang et al.   Clinical Breast Cancer

Epidemiology of Triple-Negative Breast Cancer

(2021) Frederick M. Howard et al.   CANCER JOURNAL

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

(2021) Remy Thomas et al.   Frontiers in Oncology

S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells

(2021) Maria Francesca Santolla et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1

(2021) Li-Ming Dong et al.   Frontiers in Cell and Developmental Biology

Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells

(2020) E. Ilker Ozay et al.   MOLECULAR THERAPY

Pathology of triple negative breast cancer

(2020) Filippo Borri et al.   SEMINARS IN CANCER BIOLOGY

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

(2020) Alessandra Cataldo et al.   Cancers

Triple‑negative breast cancer therapy: Current and future perspectives (Review)

(2020) Kwang‑Ai Won et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation

(2019) Romero-Cordoba et al.   Cancers

Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution

(2019) Jernej Ule et al.   MOLECULAR CELL

Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer

(2019) Francesco Fabbri et al.   SEMINARS IN CANCER BIOLOGY

Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK

(2018) Tanja Davis et al.   BIOCHEMICAL PHARMACOLOGY

Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer

(2018) Bao-Hua Yu et al.   Diagnostic Pathology

Immunotherapeutic interventions of Triple Negative Breast Cancer

(2018) Zehuan Li et al.   Journal of Translational Medicine

A brave new world of RNA-binding proteins

(2018) Matthias W. Hentze et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

(2018) Leeat Keren et al.   CELL

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer

(2018) Pushpamali De Silva et al.   EBioMedicine

hnRNPDL extensively regulates transcription and alternative splicing

(2018) Ruth Zhen Li et al.   GENE

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer

(2017) Bo Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Prognostic value of follistatin-like 3 in human invasive breast cancer

(2017) Henrique L. Couto et al.   Oncotarget

PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression

(2017) Kelly Chiang et al.   Cell Reports

Filopodia in cell adhesion, 3D migration and cancer cell invasion

(2015) Guillaume Jacquemet et al.   CURRENT OPINION IN CELL BIOLOGY

HISAT: a fast spliced aligner with low memory requirements

(2015) Daehwan Kim et al.   NATURE METHODS

Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers

(2014) Lifen Cao et al.   ANTIOXIDANTS & REDOX SIGNALING

A census of human RNA-binding proteins

(2014) Stefanie Gerstberger et al.   NATURE REVIEWS GENETICS

Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span

(2014) Marwa Amer et al.   TUMOR BIOLOGY

Computational Analysis of mRNA Expression Profiles Identifies theITGFamily andPIK3R3as Crucial Genes for Regulating Triple Negative Breast Cancer Cell Migration

(2014) Sukhontip Klahan et al.   Biomed Research International

Dynamic regulation of genome-wide pre-mRNA splicing and stress tolerance by the Sm-like protein LSm5 in Arabidopsis

(2014) Peng Cui et al.   GENOME BIOLOGY

Protein-L-isoaspartate (D-aspartate) O-methyltransferase protects cardiomyocytes against hypoxia induced apoptosis through inhibiting proapoptotic kinase Mst1

(2013) Guijun Yan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Calculating Sample Size Estimates for RNA Sequencing Data

(2013) Steven N. Hart et al.   JOURNAL OF COMPUTATIONAL BIOLOGY

KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases

(2011) Chen Xie et al.   NUCLEIC ACIDS RESEARCH

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

(2010) Cole Trapnell et al.   NATURE BIOTECHNOLOGY